StonvexLoading…
StonvexCore line items from SENS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $13.13M | $11.71M | $35.26M | $21.00M | $12.91M |
Operating Income | Not available | $-31.85M | $-68.34M | $-47.41M | $-27.81M |
Net Income | Not available | $-32.33M | $-69.10M | $-48.29M | $-28.76M |
EPS (Diluted) | $-0.63 | $-0.71 | $-1.66 | $-1.19 | $-0.04 |
Total Assets | Not available | $102.86M | $126.27M | $139.92M | $150.27M |
Total Liabilities | Not available | $68.52M | $65.22M | $61.76M | $55.55M |
Cash & Equivalents | Not available | $29.61M | $40.23M | $34.46M | $31.52M |
Free Cash Flow OCF − CapEx | Not available | $-32.14M | $-60.24M | $-41.89M | $-25.91M |
Shares Outstanding | Not available | 41.80M | 41.27M | 40.81M | 814.58M |